- Avricore has been focused on the development of a network of POC analyzers running on its HealthTab software platform in community pharmacy
- So far, its platform can check up to 27 health markers, screen diabetes, and test Covid-19
- With multiple revenue streams, a key selling point for Avricore remains its commitment to patient health and convenience
- Through its innovations and forging the right partnerships, Avricore is getting closer to consumers and presenting even more possibilities for its HealthTab platform
At the start of 2021, Avricore Health (TSX.V: AVCR) (OTCQB: AVCRF) set out to achieve four main milestones- the Abbott agreement, the Shoppers agreement, the HeathTab(TM) Pilot, and the HealthTab Rollout. As of May 31, 2021, the company had already signed a deal with Abbott to expand the distribution of its Afnion 2 analyzer in pharmacies, while on June 3, Shoppers signed an agreement to stock HealthTab for diabetes screening in 11 different locations, bringing its services closer to patients (https://ibn.fm/vFITf).
Since its inception, Avricore has been driven by the development of a network of point-of-care (“POC”) analyzers that run on the company’s HealthTab software in community pharmacies, workplaces, and…
NOTE TO INVESTORS: The latest news and updates relating to AVCRF are available in the company’s newsroom at https://ibn.fm/AVCRF
About InvestorWire
InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.
With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.
Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.
For more information, please visit https://www.InvestorWire.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer
InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@InvestorWire.com
InvestorWire is part of the InvestorBrandNetwork.
